Rene Russo - PRESIDENT AND CEO, Director at Xilio Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
PRESIDENT AND CEO, Director
Stock Symbol
XLO on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Rene Russo - trading volume in the past year for Xilio Therapeutics, Inc.

Holdings reported by Rene Russo for Xilio Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 281K $191K $0.68 Jun 16, 2025 Direct
Restricted Stock Units 133K $138K $1.04 Jan 1, 2025 Direct Common Stock
Stock Option (right to buy) 700K Nov 21, 2025 Direct Common Stock

Transactions reported by Rene Russo for Xilio Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.